Trials / Completed
CompletedNCT00000344
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
Trial of Buprenorphine/Naloxone for Treatment of Opiate Dependence
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate-dependence treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine/naloxone |
Timeline
- Completion
- 2000-08-01
- First posted
- 1999-09-21
- Last updated
- 2017-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000344. Inclusion in this directory is not an endorsement.